NCT06644183
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT07206121
- Conditions
- Breast Cancer, Breast Cancer - Infiltrating Ductal Carcinoma, Breast Diseases, +17 more
- Locations
-
- University of Texas Medical Branch at Galveston, TX Galveston, Texas, United States
NCT07018752
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Institut d'Hématologie de Basse Normandie - Service Hématologie (CHU Hôpital Côte de Nacre) Caen, France
- CHU Estaing - Service Thérapie Cellulaire et Hématologie Clinique Clermont-Ferrand, France
- Hôpital Henri Mondor - Unité Hémopathies Lymphoïdes Créteil, France
- CHU Dijon Bourgogne - Service Hématologie Clinique Dijon, France
NCT05992532
- Conditions
- Acid Sphingomyelinase Deficiency, Blood Protein Disorders, Brain Diseases, +38 more
- Locations
-
- Hospital Universitario de Álava Vitoria-Gasteiz, Alava, Spain
- Hospital Universitario Torrecárdenas Almería, Spain
- Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
- Hospital Parc Taulí Sabadell, Barcelona, Spain
NCT06287528
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Hôpital Saint Louis Paris, France
NCT06393738
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Clinical Trial Site New Haven, Connecticut, United States
- Clinical Trial Site Detroit, Michigan, United States
- Clinical Trial Site New Brunswick, New Jersey, United States
- Clinical Trial Site New York, United States
NCT05592015
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT04848064
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT07398963
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China